| Ytd | -7.65% | |
| 1y | -50.32% |
| Open | Prev Close | 4.71 | Low | High | Mkt Cap | 4.26M | |||
| Vol | 0.00 | Avg Vol | 165.95K | EPS | -3.10 | P/E | -1.52 | Forward P/E | -1.26 |
| Beta | 0.63 | Short Ratio | 0.98 | Inst. Own | 2.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 5.92 | 200-d Avg | 6.26 | 1yr Est | 10.00 |
SILO News
Silo continues to add technology assets as it expands its AI business and further develops its lead
Silo Pharma's QwikAgents joins AMD's AI Developer Program, gaining cloud credits and tools t
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta
Apple partners with Broadcom on a multiyear agreement exceeding $30 billion to develop custom silico
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular s
Gainers VYNE Therapeutics (NASDAQ:VYNE) stock increased by 17.9% to $0.79 during Friday's pre-m
Nvidia expands its life sciences AI ecosystem through a Certara partnership and QwikAgents' entr
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta
Silo Pharma (NASDAQ:SILO) ("Silo" or "the Company"), a diversified developmental-sta
Positive data supports the continued advancement of FDA Investigational New Drug (IND)- enabling dev
(Editor’s note: The future prices of benchmark tracking ETFs, the lede, the economic data and the he
SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from
U.S. stock futures down, investors should watch Levi Strauss, Silo Pharma, Greenbrier, Mach Natural
During the session on Thursday, 461 stocks hit new 52-week lows.